SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-166858
Filing Date
2023-06-14
Accepted
2023-06-14 16:07:31
Documents
18
Period of Report
2023-06-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d507995d8k.htm   iXBRL 8-K 33574
2 EX-1.1 d507995dex11.htm EX-1.1 284887
3 EX-4.1 d507995dex41.htm EX-4.1 62770
4 EX-5.1 d507995dex51.htm EX-5.1 13702
5 EX-99.1 d507995dex991.htm EX-99.1 9931
6 EX-99.2 d507995dex992.htm EX-99.2 10327
10 GRAPHIC g507995g507995.jpg GRAPHIC 5286
  Complete submission text file 0001193125-23-166858.txt   658504

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA kura-20230613.xsd EX-101.SCH 2866
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE kura-20230613_lab.xml EX-101.LAB 17995
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kura-20230613_pre.xml EX-101.PRE 11272
12 EXTRACTED XBRL INSTANCE DOCUMENT d507995d8k_htm.xml XML 3353
Mailing Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130
Business Address 12730 HIGH BLUFF DRIVE, SUITE 400 SAN DIEGO CA 92130 (858) 500-8800
Kura Oncology, Inc. (Filer) CIK: 0001422143 (see all company filings)

IRS No.: 611547851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37620 | Film No.: 231014163
SIC: 2834 Pharmaceutical Preparations